Dapsone as an Alternative Therapy in Children with Familial Mediterranean Fever

AUTHORS

Elnaz Mohammadi 1 , Sepideh Jahangiri 1 , Farhad Salehzadeh 2 , *

1 Department of Pediatrics, Ardabil University of Medical Sciences, Ardebil, Iran

2 Department of Pediatrics, Ardabil University of Medical Sciences, Ardebil

How to Cite: Mohammadi E, Jahangiri S, Salehzadeh F. Dapsone as an Alternative Therapy in Children with Familial Mediterranean Fever, Iran J Pediatr. 2016 ; 22(1):23-27.

ARTICLE INFORMATION

Iranian Journal of Pediatrics: 22 (1); 23-27
Published Online: March 31, 2012
Article Type: Research Article
Received: August 25, 2010
Accepted: July 03, 2011

Crossmark

CHEKING

READ FULL TEXT
Abstract

Objective: Familial Mediterranan Fever is an hereditary  autoinflammatory disease that presents with recurrent febrile attacks and poly serositis.  Colchicine is the only known treatment in this diease.  However,  nearly 5-10% of patients are resistant to colchicines. There are many different modalities in colchicine resistant patients,  biologic and immunosupressive drugs being the known ones. We studied the efficacy of Dapsone as an anti inflammatory drug in children with FMF who did not tolerate colchicine well.
Methods: This is a case series study in 10 patients who had FMF on the base of Tel-Hashomer criteria and did not tolerate colchicine or did not respond to it well. Patients took 2mg/kg dapsone in single dose,  during 6 months.  
Findings In four patients episodic attacks returned after 27 days,  so the drug was discontinued. One patient refused to continue the study; in five patients dapsone was taken in average for 8 months and 6 days, at least for 6 months. These five patients had no episodes of attack during the following observation.  
Conclusion: Dapsone could control episodic attacks of FMF in 50% of cases. It might be considered as an alternative therapy in FMF cases not responding to colchicine.

 

Keywords

Dapsone Familial Mediterranan Fever Periodic Fever Children

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

References

  • 1.

    References are available in PDF.

  • COMMENTS

    LEAVE A COMMENT HERE: